Tvardi Therapeutics, Inc.
TVRDNasdaqCIK 1346830HealthcareFiscal year ends Dec 31
Reports and events: 220 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1407:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-096424 |
| 2026-08-1407:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-096417 |
| 2026-07-3007:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-088461 |
| 2026-07-1716:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-084627 |
| 2026-07-0707:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-080930 |
| 2026-06-1116:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-072930 |
| 2026-05-0807:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057528 |
| 2026-05-0807:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057524 |
| 2026-04-2316:10 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001104659-26-047695 |
| 2026-03-3116:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-037729 |
| 2026-03-3116:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-037724 |
| 2026-03-0616:01 ET | 8-K | 8.01 Other events | 0001104659-26-024676 |
| 2026-01-1606:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-004273 |
| 2025-12-1817:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-122615 |
| 2025-11-1906:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-113901 |
| 2025-11-1316:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-111310 |
| 2025-11-1316:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-111289 |
| 2025-10-2017:28 ET | S-1/A | Registration statement, amended | 0001104659-25-100896 |
| 2025-10-1406:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-098908 |
| 2025-10-0716:31 ET | S-1/A | Registration statement, amended | 0001104659-25-097519 |
| 2025-08-1416:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-078665 |
| 2025-08-1416:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011562 |
| 2025-07-1417:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-067785 |
| 2025-06-0906:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-057524 |
| 2025-05-3016:03 ET | S-1 | Registration statement | 0001104659-25-054853 |
| 2025-05-2708:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-052733 |
| 2025-05-1316:26 ET | 8-K | 2.02 Results of operations; 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-25-047856 |
| 2025-05-1316:20 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-25-047844 |
| 2025-05-1316:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007575 |
| 2025-04-1616:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-054743 |
| 2025-04-1516:06 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-035121 |
| 2025-04-1116:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-034220 |
| 2025-04-0116:30 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-030583 |
| 2025-03-2416:30 ET | 8-K | 8.01 Other events | 0001104659-25-027233 |
| 2025-03-1116:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002705 |
| 2025-01-2108:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-004747 |
| 2025-01-1716:43 ET | 8-K | 8.01 Other events | 0001104659-25-004517 |
| 2024-12-3016:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-132481 |
| 2024-12-2016:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-24-130803 |
| 2024-12-1817:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-24-137983 |
| 2024-12-1807:23 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-129596 |
| 2024-11-2216:09 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-24-122099 |
| 2024-11-1416:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015713 |
| 2024-10-3016:21 ET | SC 13D | Ownership report, active investor | 0001193125-24-247585 |
| 2024-08-1416:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-012231 |
| 2024-08-0116:15 ET | 8-K | 3.01 Delisting notice | 0001104659-24-084911 |
| 2024-06-1816:16 ET | 8-K | 2.05 Exit or disposal costs | 0001104659-24-072821 |
| 2024-06-1217:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-070914 |
| 2024-06-0716:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-069625 |
| 2024-05-1316:17 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007964 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.